Company News

Share this article:

Merck inked a deal with insurance carrier Cigna to provide discounted Januvia and Janumet – both anti-diabetes medications – to Cigna customers based on drug adherence and results. If a given Cigna customer successfully lowers his or her blood sugar on Januvia and Janumet, Cigna will get a discount on the drugs. Additionally, Cigna patients adhering to their Januvia or Janumet regimens will provide the insurer with further discounts, according to a company statement.

 

Roche Madison, a Hoffman-La Roche RNA therapeutics unit, has moved into its new chemistry and biology lab facilities in Madison, Wisconsin's research park. Roche Madison is the result of Roche's purchase of Mirus Bio Corporation in 2008. The site currently employs 45, and plans to hire additional staff over the next year.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Genentech shift could prove costly for hospitals

Genentech will use specialty distributors rather than wholesalers, hospitals pharmacy directors have learned.

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies